Mingot-Castellano, M.E.; Bastida, J.M.; Caballero-Navarro, G.; Entrena Ureña, L.; González-López, T.J.; González-Porras, J.R.; Butta, N.; Canaro, M.; Jiménez-Bárcenas, R.; Gómez del Castillo Solano, M.d.C.;
et al. Novel Therapies to Address Unmet Needs in ITP. Pharmaceuticals 2022, 15, 779.
https://doi.org/10.3390/ph15070779
AMA Style
Mingot-Castellano ME, Bastida JM, Caballero-Navarro G, Entrena Ureña L, González-López TJ, González-Porras JR, Butta N, Canaro M, Jiménez-Bárcenas R, Gómez del Castillo Solano MdC,
et al. Novel Therapies to Address Unmet Needs in ITP. Pharmaceuticals. 2022; 15(7):779.
https://doi.org/10.3390/ph15070779
Chicago/Turabian Style
Mingot-Castellano, MarÃa Eva, José MarÃa Bastida, Gonzalo Caballero-Navarro, Laura Entrena Ureña, Tomás José González-López, José Ramón González-Porras, Nora Butta, Mariana Canaro, Reyes Jiménez-Bárcenas, MarÃa del Carmen Gómez del Castillo Solano,
and et al. 2022. "Novel Therapies to Address Unmet Needs in ITP" Pharmaceuticals 15, no. 7: 779.
https://doi.org/10.3390/ph15070779
APA Style
Mingot-Castellano, M. E., Bastida, J. M., Caballero-Navarro, G., Entrena Ureña, L., González-López, T. J., González-Porras, J. R., Butta, N., Canaro, M., Jiménez-Bárcenas, R., Gómez del Castillo Solano, M. d. C., Sánchez-González, B., Pascual-Izquierdo, C., & on behalf of the GEPTI.
(2022). Novel Therapies to Address Unmet Needs in ITP. Pharmaceuticals, 15(7), 779.
https://doi.org/10.3390/ph15070779